James Pipkin

Investor

Vice President, New Product Development at Ligand Pharmaceuticals

Find your path to James

18 people in our graph share verified history with James — schools, employers, funds. One of them is your warm intro.

Richard HeymanunlockedJames: together at Ligand Pharmaceuticals

×11James: together at Ligand Pharmaceuticals

About

VP of New Product Development focused on applications and IP for the Captisol cyclodextrin drug-delivery technology, joining Ligand via the 2011 CyDex acquisition. He previously directed CMC services at Oread Laboratories and was a research fellow at Merck.

Colleagues at Ligand Pharmaceuticals

Andrew Reardon

Chief Legal Officer at Ligand Pharmaceuticals

Karen Reeves

Senior Vice President, Investments and Head of Clinical Strategy at Ligand Pharmaceuticals

Keith Marschke

Senior Vice President, Biology and Scientific Affairs at Ligand Pharmaceuticals

Lauren Hay

Vice President, Portfolio Strategy and Investments at Ligand Pharmaceuticals

Lee Brown

Vice President, Investments and Business Development at Ligand Pharmaceuticals

Marjorie Fackovec

Head of People Operations at Ligand Pharmaceuticals

Michael Vigilante

Vice President, Investments and Business Development at Ligand Pharmaceuticals

Paul J. Hadden

Senior Vice President, Investments and Business Development at Ligand Pharmaceuticals

Frequently asked questions

Who is James Pipkin?: VP of New Product Development focused on applications and IP for the Captisol cyclodextrin drug-delivery technology, joining Ligand via the 2011 CyDex acquisition. He previously directed CMC services at Oread Laboratories and was a research fellow at Merck.
Where does James Pipkin work?: James Pipkin is Vice President, New Product Development at Ligand Pharmaceuticals.